Professor of Medicine
Division of Gastroenterology and Hepatology
McGill University
- Recognize and accurately diagnose nonalcoholic fatty liver disease (NAFLD) or nonalcoholic steatohepatitis (NASH) in patients with suspected symptoms through a comprehensive assessment that includes a physical examination, medical history, laboratory/blood tests, and diagnostic imaging.
- Evaluate critically the most up-to-date efficacy and safety data of current and emerging NAFLD/NASH therapies, analyzing and interpreting potential risks and benefits of each therapy and identifying contraindications, drug interactions, and other safety concerns.
- Develop and apply an effective management strategy for NAFLD/NASH patients that incorporates the most suitable lifestyle interventions and pharmaceutical therapies while considering patient preferences and potential comorbidities.